C/EBPα mutations in lung cancer

Lung Cancer

Volumn 53, Issue 2, 2006, Pages 253-254

  Costa, Daniel B ^a   Dayaram, Tajhal ^a   D'Alo, Francesco ^a   Wouters, Bas J ^a   Tenen, Daniel G ^a   Meyerson, Matthew ^a   Tsao, Ming Sound ^b   Halmos, Balazs ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

C EBP ; Epigenetic; Lung cancer; Methylation; Mutation; Transcription factor

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; BASE PAIRING; CANCER CELL; DOWN REGULATION; FRAMESHIFT MUTATION; GENE CONTROL; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; LETTER; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STOP CODON; TUMOR SUPPRESSOR GENE;

ACUTE DISEASE; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; CARCINOMA, NON-SMALL-CELL LUNG; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; DOWN-REGULATION; EPITHELIAL CELLS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA, MYELOID; LUNG NEOPLASMS; MUTATION;

EID: 33745619767     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.04.011     Document Type: Letter

References (8)

1. Basseres D.S., Levantini E., Ji H., Monti S., Elf S., Dayaram T., et al. Respiratory failure due to differentiation arrest and expansion of alveolar cells following lung-specific loss of the transcription factor C/EBPalpha in mice. Mol Cell Biol 26 3 (2006) 1109-1123
2. Halmos B., Huettner C.S., Kocher O., Ferenczi K., Karp D.D., and Tenen D.G. Down-regulation and antiproliferative role of C/EBPalpha in lung cancer. Cancer Res 62 2 (2002) 528-534
3. Tada Y., Brena R.M., Hackanson B., Morrison C., Otterson G.A., and Plass C. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein α activity in lung cancer. J Natl Cancer Inst 98 6 (2006) 396-406
4. Pabst T., Mueller B.U., Harakawa N., Schoch C., Haferlach T., Behre G., et al. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. Nat Med 7 4 (2001) 444-451
5. Pabst T., Mueller B.U., Zhang P., Radomska H.S., Narravula S., Schnittger S., et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 27 3 (2001) 263-270
6. Preudhomme C., Sagot C., Boissel N., Cayuela J.M., Tigaud I., de Botton S., et al. Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA). Blood 100 8 (2002) 2717-2723
7. Frohling S., Schlenk R.F., Stolze L., Bihlmayr J., Benner A., Kreitmeier S., et al. CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. J Clin Oncol 22 4 (2004) 624-633
8. Gombart A.F., Hofmann W.K., Kawano S., Takeuchi S., Krug U., Kwok S.H., et al. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias. Blood 99 4 (2002) 1332-1340